[go: up one dir, main page]

AU2382601A - Novel method of treatment - Google Patents

Novel method of treatment

Info

Publication number
AU2382601A
AU2382601A AU23826/01A AU2382601A AU2382601A AU 2382601 A AU2382601 A AU 2382601A AU 23826/01 A AU23826/01 A AU 23826/01A AU 2382601 A AU2382601 A AU 2382601A AU 2382601 A AU2382601 A AU 2382601A
Authority
AU
Australia
Prior art keywords
treatment
novel method
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23826/01A
Inventor
Robin Edward Buckingham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930688.8A external-priority patent/GB9930688D0/en
Priority claimed from GBGB9930689.6A external-priority patent/GB9930689D0/en
Priority claimed from GBGB9930690.4A external-priority patent/GB9930690D0/en
Priority claimed from GBGB9930692.0A external-priority patent/GB9930692D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2382601A publication Critical patent/AU2382601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU23826/01A 1999-12-24 2000-12-22 Novel method of treatment Abandoned AU2382601A (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9930688.8A GB9930688D0 (en) 1999-12-24 1999-12-24 Novel method of treatment
GB9930690 1999-12-24
GBGB9930689.6A GB9930689D0 (en) 1999-12-24 1999-12-24 Novel method of treatment
GB9930689 1999-12-24
GB9930688 1999-12-24
GBGB9930690.4A GB9930690D0 (en) 1999-12-24 1999-12-24 Novel method of treatment
GBGB9930692.0A GB9930692D0 (en) 1999-12-24 1999-12-24 Novel method of treatment
GB9930692 1999-12-24
PCT/GB2000/005006 WO2001047509A2 (en) 1999-12-24 2000-12-22 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions

Publications (1)

Publication Number Publication Date
AU2382601A true AU2382601A (en) 2001-07-09

Family

ID=27451929

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23826/01A Abandoned AU2382601A (en) 1999-12-24 2000-12-22 Novel method of treatment

Country Status (4)

Country Link
EP (1) EP1261373A2 (en)
JP (1) JP2003518493A (en)
AU (1) AU2382601A (en)
WO (1) WO2001047509A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051441A1 (en) * 2000-12-26 2002-07-04 Sankyo Company, Limited Medicinal compositions containing diuretic and insulin resistance-improving agent
CN1465712A (en) * 2002-07-05 2004-01-07 安徽省生物医学研究所 Kit, method, software and compound medicine for predicting effect of ACEI antihypertensive medicine
US8455432B2 (en) 2007-01-25 2013-06-04 Verva Pharmaceuticals Ltd. Insulin sensitisers and methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ES2250283T3 (en) * 1996-07-15 2006-04-16 Sankyo Company Limited USE OF CS-866 (OLMESARTAN) IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ARTERIOSCLEROSIS.
HK1041201A1 (en) * 1998-11-11 2002-07-05 Smithkline Beecham Plc Compatibility of beta agonists and antidiabetic agents

Also Published As

Publication number Publication date
JP2003518493A (en) 2003-06-10
WO2001047509A2 (en) 2001-07-05
WO2001047509A3 (en) 2002-09-12
EP1261373A2 (en) 2002-12-04

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
AU2001286983A1 (en) Method of treatment
AU2001262177A1 (en) Method of treatment
AU4598400A (en) Method of treatment
GB9930688D0 (en) Novel method of treatment
AU2382601A (en) Novel method of treatment
AU1108101A (en) Method of treating plants
AU2001253560A1 (en) Methods of treatment
AU8038400A (en) Method of treatment of influenza
AUPQ233299A0 (en) Method of treatment
AUPQ080999A0 (en) Method of treatment
AUPQ320299A0 (en) Method of treatment
GB9930696D0 (en) Novel method of treatment
GB9930690D0 (en) Novel method of treatment
GB0122638D0 (en) Novel method of treatment
GB9930692D0 (en) Novel method of treatment
GB9930689D0 (en) Novel method of treatment
AUPP225098A0 (en) Method of treatment
AUPP363398A0 (en) Method of treatment
AUPP584798A0 (en) Method of treatment
AUPP193198A0 (en) Method of treatment
HK1035669A (en) Method of treatment
HK1037530A (en) Method of treatment
AUPP460798A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase